A 6-month bioassay in A/J mice was conducted to test the hypothesis th
at chronically inhaled mainstream cigarette smoke would either induce
lung cancer or promote lung carcinogenicity induced by the tobacco-spe
cific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK
). Groups of 20 female A/J mice were exposed to filtered air (FA) or c
igarette smoke (CS), injected with NNK, or exposed to both CS and NNK.
At 7 weeks of age, mice were injected once with NNK; 3 days later, th
ey were exposed to CS for 6 h/day, 5 days/week, for 26 weeks at a mean
248 mg total particulate matter/m(3) concentration. Animals were sacr
ificed 5 weeks after exposures ended for gross and histological evalua
tion of lung lesions. No significant differences in survival between e
xposure groups was observed. A biologically significant level of CS-ex
posure was achieved as indicated by CS-induced body weight reductions,
lung weight increases, and carboxyhemoglobin levels in blood of about
17%. Crude tumor incidences, as determined from gross observation of
lung nodules, were similar between the CS-exposed and FA groups, surd
the NNK and CS + NNK groups. Incidences in either of these latter grou
ps were greater than either the CS or FA groups. Furthermore, tumor mu
ltiplicity in tumor-bearing animals was not significantly different am
ong any of the three groups (FA., NNK, CS + NNK) in which tumors were
observed. Thus, CS exposure neither induced lung tumors nor promoted N
NK-induced tumors. Because the Cs exposure concentration was probably
near the maximally tolerable level, longer exposures should be evaluat
ed to potentially establish a CS-induced model of lung carcinogenesis
in the A/J mouse.